Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
3 Pharma Stocks to Buy as Summer COVID Cases Spike
05:11am, Wednesday, 23'rd Aug 2023
Covid-19 related stocks started spiking again this week. Driven primarily by reports about new variants and increasing spread.
Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
02:37am, Tuesday, 15'th Aug 2023
Quest Diagnostics has a strong Q2 with a slight beat on EPS and revenue. Quest's base business appears to be recovering from the pandemic and pulled in $2.30B in revenue. Despite fading COVID-related
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
11:39am, Monday, 14'th Aug 2023
Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and acquisitions.
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection
09:53am, Wednesday, 09'th Aug 2023
Biogen and Eli Lilly both have treatments to help reduce cognitive decline in Alzheimer's patients. But the key to their effectiveness is in treating people who have the disease in its early stages.
Looking for a Bargain? 3 Stocks to Buy That Are Down 10% in 2023
06:00am, Wednesday, 02'nd Aug 2023
Walking into the latter half of 2023, we're looking at a very different stock market than a year ago. Despite elevated interest rates and ongoing inflation, the S&P 500 is up for the fifth consecutive
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer's disease
07:23am, Monday, 31'st Jul 2023
Quest Diagnostics Inc. DGX, +0.10% said Monday it has brought the first blood-based biomarker test to assess the risk of developing Alzheimer's disease to market and it's now available for consumer pu
Quest Diagnostics launches Alzheimer's blood test for consumers
07:10am, Monday, 31'st Jul 2023
Quest Diagnostics on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein which can appear years before dementia symptoms arise.
Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates
09:25am, Wednesday, 26'th Jul 2023
Quest Diagnostics (DGX) came out with quarterly earnings of $2.30 per share, beating the Zacks Consensus Estimate of $2.23 per share. This compares to earnings of $2.36 per share a year ago.
Quest Diagnostics beats profit estimates as routine testing picks up
07:56am, Wednesday, 26'th Jul 2023
Laboratory operator Quest Diagnostics Inc beat estimates for quarterly profit on Wednesday, as people returned for regular checkups and tests that were delayed during a large part of the COVID-19 pand
Final Trades: Quest Diagnostics, Keysight & more
02:32pm, Tuesday, 18'th Jul 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Quest Diagnostics (DGX) to Post Q2 Earnings: What's in Store?
01:35pm, Tuesday, 18'th Jul 2023
Quest Diagnostics (DGX) second-quarter results are likely to have reflected the solid base business performance and benefits from acquisitions.
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
12:50pm, Tuesday, 18'th Jul 2023
Investors are optimistic about Quest Diagnostics (DGX) on stronger base volume recovery and growth from strategic acquisitions.
Quest Diagnostics (DGX) Brings New Test for Prostate Cancer
08:53am, Friday, 14'th Jul 2023
Quest Diagnostics (DGX) collaborates with Envision Sciences to bring a novel prosate cancer biomarker test.
Quest Diagnostics' (DGX) New Pact to Get Home Fertility Test
11:45am, Monday, 10'th Jul 2023
The Proov Confirm home collection kit can be purchased now on Quest Diagnostics' questhealth.com for $29.
Quest Diagnostics (DGX) Presents New Data on Disease Testing
12:12pm, Monday, 03'rd Jul 2023
Quest Diagnostics (DGX) is dedicated to create cutting-edge laboratory tests to help assess patient risk for dementia and other degenerative diseases.
